These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 6132996)

  • 1. Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms.
    Bick AJ; Avenant C; Tomasicchio M; van der Spuy Z; Hapgood JP
    Am J Reprod Immunol; 2022 Dec; 88(6):e13643. PubMed ID: 36302121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Sequencing Reveals Distinct Immune Responses in the Chorioamniotic Membranes of Women with Preterm Labor and Microbial or Sterile Intra-amniotic Inflammation.
    Motomura K; Romero R; Galaz J; Tarca AL; Done B; Xu Y; Leng Y; Garcia-Flores V; Arenas-Hernandez M; Theis KR; Gershater M; Jung E; Hsu CD; Gomez-Lopez N
    Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33558326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions.
    Szekeres-Bartho J; Šućurović S; Mulac-Jeričević B
    Front Immunol; 2018; 9():2890. PubMed ID: 30619262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between the composition of maternal peripheral plasma and plasma collected from the retroplacental compartment at caesarean section. A study on protein and steroid hormones and binding proteins.
    Norman M; Eriksson CG; Eneroth P
    Arch Gynecol Obstet; 1989; 244(4):215-26. PubMed ID: 2476972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity and progesterone binding capacity of maternal lymphocytes are not influenced by gestational age and by the number of previous pregnancies.
    Szekeres J; Csernus V; Hadnagy J; Pácsa AS
    Acta Med Acad Sci Hung; 1982; 39(3-4):137-43. PubMed ID: 7185239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone-prostaglandin balance influences lymphocyte function in relation to pregnancy.
    Szekeres-Barthó J; Csernus V; Hadnagy J; Pacsa AS
    Am J Reprod Immunol (1980); 1983; 4(3):139-41. PubMed ID: 6581738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of treatment with prostaglandin synthesis inhibitor or progesterone on cytotoxic activity and progesterone binding capacity of lymphocytes during pregnancy.
    Szekeres-Bartho J; Csernus V; Hadnagy J; Pacsa AS
    Prostaglandins; 1983 Aug; 26(2):187-95. PubMed ID: 6647870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive effect of progesterone on lymphocyte cytotoxicity: unique progesterone sensitivity of pregnancy lymphocytes.
    Szekeres-Bartho J; Hadnagy J; Pacsa AS
    J Reprod Immunol; 1985 Feb; 7(2):121-8. PubMed ID: 3981485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive effect of serum progesterone during pregnancy depends on the progesterone binding capacity of the lymphocytes.
    Szekeres-Bartho J; Csernus V; Hadnagy J; Pacsa AS
    J Reprod Immunol; 1983 Mar; 5(2):81-8. PubMed ID: 6132996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of progesterone and progestin therapy in threatened abortion and preterm labour.
    Szekeres-Bartho J; Wilczynski JR; Basta P; Kalinka J
    Front Biosci; 2008 Jan; 13():1981-90. PubMed ID: 17981685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIBF: the double edged sword. Pregnancy and tumor.
    Szekeres-Bartho J; Polgar B
    Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.